Swiss National Bank Repligen Corp Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Repligen Corp stock. As of the latest transaction made, Swiss National Bank holds 103,800 shares of RGEN stock, worth $17.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
103,800
Previous 156,900 33.84%
Holding current value
$17.3 Million
Previous $19.8 Million 21.9%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$119.79 - $167.35 $6.36 Million - $8.89 Million
-53,100 Reduced 33.84%
103,800 $15.4 Million
Q2 2024

Aug 08, 2024
SELL
$120.0 - $182.95 $228,000 - $347,605
-1,900 Reduced 1.2%
156,900 $19.8 Million
Q1 2024

May 07, 2024
SELL
$170.78 - $208.42 $1.16 Million - $1.42 Million
-6,800 Reduced 4.11%
158,800 $29.2 Million
Q4 2023

Feb 06, 2024
SELL
$114.17 - $185.35 $513,765 - $834,075
-4,500 Reduced 2.65%
165,600 $29.8 Million
Q3 2023

Nov 08, 2023
SELL
$138.78 - $176.51 $2.89 Million - $3.67 Million
-20,800 Reduced 10.9%
170,100 $27 Million
Q2 2023

Aug 09, 2023
SELL
$138.42 - $180.31 $2.49 Million - $3.25 Million
-18,000 Reduced 8.62%
190,900 $27 Million
Q1 2023

May 10, 2023
SELL
$154.26 - $198.1 $802,152 - $1.03 Million
-5,200 Reduced 2.43%
208,900 $35.2 Million
Q4 2022

Feb 08, 2023
BUY
$162.42 - $220.56 $14.5 Million - $19.7 Million
89,200 Added 71.42%
214,100 $36.2 Million
Q3 2022

Nov 09, 2022
BUY
$160.42 - $256.21 $160,420 - $256,209
1,000 Added 0.81%
124,900 $23.4 Million
Q2 2022

Aug 09, 2022
SELL
$140.68 - $188.02 $42,204 - $56,406
-300 Reduced 0.24%
123,900 $20.1 Million
Q1 2022

May 09, 2022
BUY
$161.19 - $257.96 $1.48 Million - $2.37 Million
9,200 Added 8.0%
124,200 $23.4 Million
Q4 2021

Feb 08, 2022
SELL
$247.59 - $304.47 $49,518 - $60,894
-200 Reduced 0.17%
115,000 $30.5 Million
Q3 2021

Nov 08, 2021
BUY
$194.77 - $324.21 $97,385 - $162,105
500 Added 0.44%
115,200 $33.3 Million
Q2 2021

Aug 06, 2021
BUY
$165.87 - $220.95 $66,348 - $88,380
400 Added 0.35%
114,700 $22.9 Million
Q1 2021

May 07, 2021
BUY
$180.37 - $226.26 $270,555 - $339,390
1,500 Added 1.33%
114,300 $22.2 Million
Q4 2020

Feb 05, 2021
BUY
$148.08 - $206.57 $29,616 - $41,314
200 Added 0.18%
112,800 $21.6 Million
Q3 2020

Nov 09, 2020
BUY
$122.51 - $158.27 $257,271 - $332,367
2,100 Added 1.9%
112,600 $16.6 Million
Q2 2020

Aug 05, 2020
BUY
$94.33 - $140.48 $1.85 Million - $2.75 Million
19,600 Added 21.56%
110,500 $13.7 Million
Q1 2020

May 08, 2020
BUY
$84.96 - $109.14 $186,912 - $240,108
2,200 Added 2.48%
90,900 $8.78 Million
Q4 2019

Feb 06, 2020
BUY
$73.84 - $93.08 $539,032 - $679,484
7,300 Added 8.97%
88,700 $8.21 Million
Q3 2019

Nov 12, 2019
BUY
$76.65 - $95.51 $605,535 - $754,529
7,900 Added 10.75%
81,400 $6.24 Million
Q2 2019

Aug 02, 2019
BUY
$54.2 - $85.95 $303,520 - $481,320
5,600 Added 8.25%
73,500 $6.32 Million
Q1 2019

May 10, 2019
BUY
$49.45 - $62.8 $103,845 - $131,880
2,100 Added 3.19%
67,900 $4.01 Million
Q4 2018

Feb 13, 2019
BUY
$48.26 - $68.88 $43,434 - $61,991
900 Added 1.39%
65,800 $3.47 Million
Q1 2018

May 04, 2018
BUY
$30.92 - $37.27 $37,104 - $44,724
1,200 Added 1.88%
64,900 $2.35 Million
Q4 2017

Feb 07, 2018
BUY
$32.53 - $38.92 $104,096 - $124,544
3,200 Added 5.29%
63,700 $2.31 Million
Q3 2017

Nov 03, 2017
BUY
$36.98 - $46.06 $2.24 Million - $2.79 Million
60,500
60,500 $2.32 Million

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
54.5M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.22B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email